Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Waning but dormant SARS (Severe Acute Respiratory Syndrome) still a priority:

This article was originally published in Clinica

Executive Summary

The global spread of Severe Acute Respiratory Syndrome (SARS) may be waning, but the World Health Organization (WHO) remains on guard, amid concerns that the disease might return with a vengeance later this year. Such was the consensus among the 800 experts gathered at last week's SARS summit in Malaysia. The development of a viable diagnostic test remains a priority. As Clinica went to press on Wednesday June 25, the number of cases worldwide stood at 8,460, with 810 deaths. The most recent cases were reported in Canada and the US.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT062708

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel